de Vries, Isabelle S. A. http://orcid.org/0000-0001-8289-4164
van Ewijk, Roelof http://orcid.org/0000-0003-0339-6031
Adriaansen, Laura M. E.
Bohte, Anneloes E. http://orcid.org/0000-0001-6814-6952
Braat, Arthur J. A. T. http://orcid.org/0000-0002-8824-8697
Fajardo, Raquel Dávila http://orcid.org/0000-0002-4729-825X
Hiemcke-Jiwa, Laura S. http://orcid.org/0000-0002-0332-1673
Hol, Marinka L. F. http://orcid.org/0000-0003-4926-056X
ter Horst, Simone A. J. http://orcid.org/0000-0003-4849-5826
de Keizer, Bart http://orcid.org/0000-0002-6270-9483
Knops, Rutger R. G. http://orcid.org/0000-0002-2795-3253
Meister, Michael T. http://orcid.org/0000-0001-8311-721X
Schoot, Reineke A. http://orcid.org/0000-0002-8838-981X
Smeele, Ludi E.
van Scheltinga, Sheila Terwisscha http://orcid.org/0000-0001-7993-0208
Vaarwerk, Bas http://orcid.org/0000-0003-1336-0112
Merks, Johannes H. M. http://orcid.org/0000-0001-7659-1028
van Rijn, Rick R. http://orcid.org/0000-0002-8876-6515
Article History
Received: 30 August 2022
Revised: 6 October 2022
Accepted: 10 January 2023
First Online: 27 February 2023
Change Date: 17 March 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00247-023-05642-5
Declarations
:
: Additional informed consent was obtained from the parents of both patients for whom medical information and imaging are included in this article.
: Arthur J.A.T. Braat has acted as a consultant for Terumo and Boston Scientific. Johannes H.M. Merks has a consulting or advisory role for Bayer, GlaxoSmithKline, and Merck. Reineke A. Schoot’s institution received funding for research by Pfizer and Takeda; no conflicts are expected with regard to this paper.